RCMC
IRWD icon

Rubric Capital Management (Connecticut)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Rubric Capital Management (Connecticut)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,668,107
Closed -$74.4M – 18
2015
Q4 		$74.4M Hold
7,668,107
– – 6.49% 1
2015
Q3 		$66.9M Buy
+7,668,107
New +$71.6M 6.55% 3

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Rubric Capital Management (Connecticut)'s IRWD Position: Q1 2016 in Review

Rubric Capital Management (Connecticut) sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2016, closing a stake of 7,668,107 shares — an estimated $74.4M sold.

Rubric Capital Management (Connecticut) first reported a position in IRWD in Q3 2015 and held it in 2 quarters. The position peaked at $74.4M in Q4 2015. 136 funds tracked by Wall St. Rank hold IRWD as of Q1 2016.

  • Rubric Capital Management (Connecticut) reported no remaining Ironwood Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Rubric Capital Management (Connecticut) sold 7,668,107 Ironwood Pharmaceuticals shares in Q1 2016, an estimated $74.4M.
  • Rubric Capital Management (Connecticut) first reported a position in Ironwood Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Rubric Capital Management (Connecticut)'s Ironwood Pharmaceuticals position peaked at $74.4M in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2016.

Based on Rubric Capital Management (Connecticut)'s 13F filing for Q1 2016, filed 16 May 2016.